5-Cyano-2-[4-butoxycarbonyl-1-(1,4-diazepenyl)]pyridine, 1g

(4R,5S)-4,5-Diphenyl-2-(6-phenylpyridin-2-yl)-4,5-dihydrooxazole, 98%, 250mg

2-(3-(2-Bromoethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

(E)-ETHYL 3-(1-METHYL-1H-PYRAZOL-4-YL)ACRYLATE, 95.0%, 5g

1-[(oxiran-2-yl)methyl]piperidine, 95.0%, 10g

4-Bromo-3-methylisoquinoline, 95.0%, 100mg

3,3-Dimethoxy-oxetane, 95.0%, 1g

4-Oxo-1,4-dihydroquinoline-3-carboxylic acid, 95.0%, 25g

(2,5-Dimethyl-benzenesulfonylamino)-acetic acid, 95.0%, 250mg

(S)-4-ISOPROPYL-2-(ISOQUINOLIN-1-YL)-4,5-DIHYDROOXAZOLE, 95%, 100mg

4-bromo-6-methoxy-1,3-benzothiazol-2-amine, 95+%, 500mg

1-[(1,3-Dimethyl-1H-pyrazol-5-yl)methyl]-1,2,3,4-tetrahydro-N-(1-methylcyclopropyl)-3-[(2-methyl-5-thiazolyl)methyl]-2,4-dioxo-6-quinazolinesulfonamide, 98%, 25mg

(6-Phenylnaphthalen-2-yl)boronic acid, 95.0%, 1g